This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.
Study Type
OBSERVATIONAL
Enrollment
535
Recurrent ischemic stroke and/or death in a well-defined Young ESUS cohort
Time frame: Approximately 18 Months
Recurrent ischemic stroke in a well-defined Young ESUS cohort
Time frame: Approximately 18 Months
Prevalence of Patent Foramen Ovale in a well-defined Young ESUS cohort
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Stanford University
Stanford, California, United States
Presence Saint Joseph Medical Center
Joliet, Illinois, United States
Guilford Neurologic Associates
Greensboro, North Carolina, United States
Oregon Health and Science University
Portland, Oregon, United States
University of South Carolina - School of Medicine - Neurology
Columbia, South Carolina, United States
Texas Tech University Health Sciences Center El Paso
El Paso, Texas, United States
University of Texas Health Center - San Antonio
San Antonio, Texas, United States
Fundacion para la Lucha vs. Enf. Neurologicas de la Infancia
Buenos Aires, Buenos Aires, Argentina
Complejo Médico de la PFA Churruca Visca
Buenos Aires, Buenos Aires, Argentina
Royal Adelaide Hospital
Adelaide, South Australia, Australia
...and 34 more locations